Home Cart Sign in  
Chemical Structure| 1174043-16-3 Chemical Structure| 1174043-16-3

Structure of AZD-2461
CAS No.: 1174043-16-3

Chemical Structure| 1174043-16-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AZD2461 is a PARP inhibitor that inhibits the activity of PARP1, PARP2, and PARP3.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AZD-2461

CAS No. :1174043-16-3
Formula : C22H22FN3O3
M.W : 395.43
SMILES Code : O=C1NN=C(CC2=CC=C(F)C(C(N3CCC(OC)CC3)=O)=C2)C4=C1C=CC=C4
MDL No. :MFCD24386811
InChI Key :HYNBNUYQTQIHJK-UHFFFAOYSA-N
Pubchem ID :44199317

Safety of AZD-2461

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of AZD-2461

epigenetics
DNA

Isoform Comparison

Biological Activity

Target
  • PARP

In Vitro:

Cell Line
Concentration Treated Time Description References
A2780 cells 0–20 μM 72 hours To assess the sensitivity of A2780 cells to AZD2461, results showed no cross-resistance to AZD2461 in A2780 cells. PMC4985349
A2780pacR cells 0–20 μM 72 hours To assess the sensitivity of A2780pacR cells to AZD2461, results showed no cross-resistance to AZD2461 in A2780pacR cells. PMC4985349
A2780olapR cells 0–20 μM 72 hours To assess the sensitivity of A2780olapR cells to AZD2461, results showed no cross-resistance to AZD2461 in A2780olapR cells. PMC4985349
PaCa44 10 μM 36 hours To evaluate the effect of AZD2461 on pancreatic cancer cell survival, results showed significant reduction in cell viability when combined with VPA and TSA. PMC8878079
Panc1 10 μM 36 hours To evaluate the effect of AZD2461 on pancreatic cancer cell survival, results showed significant reduction in cell viability when combined with VPA and TSA. PMC8878079
OVCAR8 ovarian cancer cells 100 μM - 0.064 nM 1 hour Evaluate the affinity of compounds for the PARP-1 enzyme and calculate the 50% maximum inhibition values (IC50) PMC6378121
SUP-B15 1.5 µM 24 hours AZD2461 demonstrated cytotoxicity comparable to imatinib in the SUP-B15 cell line, inducing early apoptosis and significantly inhibiting the cell cycle PMC10705790

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mouse K14cre;Brca1F/F;p53F/F (KB1P) mouse model Oral 50 mg/kg Twice daily for 15 days To evaluate the long-term therapeutic efficacy of AZD2461 in BRCA1-deficient mouse mammary tumors, results showed that AZD2461 significantly prolonged the survival of mice and suppressed the development of resistance during long-term treatment. PMC7518105
Mouse BRCA1-deficient metaplastic breast cancer model Oral 1 × 10^6 cells/mouse Single transplantation, monitored for 42 days To evaluate the therapeutic effect of AZD-2461 on BRCA1-deficient metaplastic breast cancer, the results showed that AZD-2461 effectively inhibited tumor growth. PMC4500240
Rhesus macaques Intravenous injection 50 mg/kg Twice daily for 24 hours Evaluate the brain uptake of [18F]9e in non-human primates, showing no appreciable brain uptake of [18F]9e PMC6378121

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.53mL

0.51mL

0.25mL

12.64mL

2.53mL

1.26mL

25.29mL

5.06mL

2.53mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories